Economics in Pediatric Type 1 Diabetes - Results from Recently Published Studies

Abstract

Objective: Type 1 diabetes in childhood is increasing worldwide. Several therapy components and models of pediatric diabetes care have been introduced. Economic aspects are of increasing interest to decide appropriate strategies in clinical practice. However, knowledge in pediatric diabetes is limited.

Methods: We conducted a literature research to identify and describe systematically recently published analyses on the economics of pediatric diabetes.

Results: We substracted ten analyses. Four were cost of illness studies. The main result is that hospitalization, mainly due to metabolic control, education, and acute complications, seems to be a large cost component. Only one study took the perspective of society, including indirect costs. Four of the six studies which evaluated interventions in pediatric diabetes care focussed on ambulatory or home care strategies. Detailed evaluation of new technologies, pharmacotherapy, or screening for late complications is lacking. Except one, all studies performed cost comparison analyses. Evidence is limited, however, diabetes care models may be effective and, possibly, cost saving compared to routine care.

Conclusions: Health economic studies in pediatric diabetes are scarse and limited with respect to topics and quality. Hospitalization has a large impact on health care costs in diabetic children and adolescents. Models in pediatric diabetes care like home intervention may be cost effective compared to more traditional strategies of care. However, further studies are warranted which evaluate clinical and cost effectiveness in pediatric diabetes.

Review - economic analyses - pediatric diabetes

References

• 1 Allen HF, Yarnie S, Murray MA, Reiter EO. Personnel costs and perceived benefit of telephone care in the management of children with type 1 diabetes.  Pediatr Diabetes. 2002;  3 95-100
• 2 Anonymous . Outpatient diabetes center cuts inpatient costs.  Hosp Case Manag. 1998;  6 212-214
• 3 Barlow JH, Ellard DR. Psycho-educational interventions for children with chronic disease, parents and siblings: an overview of the research evidence base.  Child: Health, Care, Development. 2004;  30 637-645
• 4 Beck JK, Logan KJ, Hamm RM, Sproat SM, Musser KM, Everhart PD, MacDermott HM, Copeland KC. Reimbursement for pediatric diabetes intensive case management: a model for chronic diseases?.  Pediatrics. 2004;  113 47-50
• 5 , BMJ: Checklist for Health Economic Papers http://www.bmj.com
• 6 Cameron FJ, Widdison J, Boyce D, Gebert R. A comparison between optimal and actual health care costs of adolescents with diabetes.  Paedriatr Child Health. 2004;  40 56-59
• 7 Chase HP, Pearson JA, Wightman C, Roberts MD, Oderberg AD, Garg SK. Modem transmission of glucose values reduces the cost and need for clinic visits.  Diabetes Care. 2003;  26 1475-1479
• 8 Clar C, Waugh N, Thomas S. Routine hospital admission versus out-patient or home care in children at diagnosis of type 1 diabetes mellitus (Cochrane Review). The Cochrane Library, Issue 2. 2003 Oxford: Update Software Ltd
• 9 Colquitt JL, Green C, Sidhu MK, Hartwell D, Waugh N. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.  HTA. 2004;  8 43
• 10 Dougherty GE, Soderstrom L, Schiffrin A. An ecomonic evaluation of home care for children with newly diagnosed diabetes: results from a randomized controlled trial.  Med Care. 1998;  36 586-598
• 11 Dougherty G, Schiffrin A, White D, Soderstrm L, Sufrategui M. Home-based management can achieve intensification cost-effectiveness in type 1 diabetes.  Pediatrics. 1999;  103 122-128
• 12 Drummond MF, O'Brien BJ, Stoddart GL, Torrance WG. Methods for the economic evaluation of health care programs. 2nd edition Oxford University Press New York 1997
• 13 Eastman RC, Leptien AD, Chase HP. Cost-effectiveness of use of the GlucoWatchBiographer in children and adolescents with type 1 diabetes: a preliminary analysis based on a randomised controlled trial.  Pediatr Diabetes. 2003;  4 82-86
• 14 EURODIAB ACE Study Group . Variation and trends in incidence of childhood diabetes in Europe.  Lancet. 2001;  355 873-876
• 15 Feltbower RG, Campbell FM, Bodansky HJ, Stephenson CR, MacKinney PA. Insulin pump therapy in choldhood diabetes - cost implications for Primary Care Trust.  Diabet Med. 2005;  23 86-89
• 16 Hahl J, Simell T, Ilonen J, Knip M, Simell O. Costs of predicting IDDM.  Diabetologia. 1998;  41 79-85
• 17 Hahl J, Simell T, Kupila A, Keskinen P, Knip M, Ilonen J, Simell O. A simulation model for estimating direct costs of type 1 diabetes prevention.  Pharmacoeconomics. 2003;  21 295-303
• 18 Icks A, Rosenbauer J, Holl RW, Grabert M, Giani G. Hospitalization in diabetic children and adolescents and in the general population.  Diabetes Care. 2001;  24 435-440
• 19 Icks A, Rosenbauer J, Haastert B, Rathmann W, Gandjour A, Giani G. Direct costs for care of diabetic children and adolescents in the first course after onset in Germany.  J Pediatr Endocrinol Metab. 2004;  17 1551-1559
• 20 Icks A, Rosenbauer J, Haastert B, Rathmann W, Grabert M, Gandjour A, Giani G, Holl RW. Direct costs of pediatric diabetes care in Germany and their predictors.  Exp Clin Endocrinol Diabetes. 2004;  112 302-309
• 21 Icks A, Rathmann W, Rosenbauer J, Giani G. Gesundheitsberichterstattung des Bundes.  Themenheft Diabetes. Hrsg. Robert-Koch-Institut 2005
• 22 Kirkland JL, Copeland KC. Telephone charges and payments in a diabetes clinic.  Pediatrics. 1998;  101 2-3
• 23 Laffel LMB, Brackett J, Ho J, Anderson BJ. Changing the process of diabetes care improves metabolic outcomes and reduces hospitalization.  Quality Management in Health Care. 1998;  6 53-62
• 24 MacEvilly A, Kirk J. Twenty years of a multidisciplinary paediatric diabetes home care unit.  Arch Dis Child. 2005;  90 342-345
• 25 Meinhard. et al . Microalbuminuria in diabetes mellitus: efficacy of a new screening method in comparison with timed overnight urine collection.  Diabetes Complications. 2003;  17 254-257
• 26 Melzer SM, Richards GE, Covington ML. Reimbursement and costs of pediatric ambulatory diabetes care by using the resource-based relative value scale: is multidisciplinary care financially viable?.  Pediatr Diabetet. 2004;  5 133-142
• 27 NHS Economic Evaluation Database (NHS EED) . , Available from URL: http://nhscrdyork.ac.uk/nhsdhp.htm
• 28 Nordfeldt S, Jonsson D. Short-term effects of severe hypoglycaemia in children and adolescents with type 1-diabetes. A cost-of-illness study.  Acta Paediatr. 2001;  90 137-142
• 29 Nordfeldt S, Johansson C, Carlsson E, Hammersjö J-A. Prevention of severe hypoglycaemia in type 1 diabetes: a randomised controlled population study.  Arch Dis Child. 2003;  88 240-245
• 30 Parker G, Bhakta P, Lovett CA, Paisley S, Olsen R, Turner D, Young B. A systematic review of the costs and effectiveness of different models of paediatric home care.  HTA. 2002;  6 35
• 31 Raikou M, MacGuire A. The economics of screening and treatment in type 2 diabetes mellitus.  Pharmacoeconomics. 2003;  8 543-564
• 32 Rosenbauer J, Icks A, Giani G. Incidence and prevalence of childhood diabetes in Germany - model-based national estimates.  Journ Pediat Endocrinol Metabolism. 2002;  15 1497-1504
• 33 Simell T, Sintonen H, Hahl J, Simell OG. Costs of insulin-dependent diabetes mellitus.  Pharmacoeconomics. 1996;  9 24-38
• 34 Stern E, Benbassat CA, Nahshoni A, Blum I. Hospitalization for general conditions among diabetic patients in Israel.  IMAJ. 2001;  3 21-23
• 35 Vanelli M, Chiari G, Capuano C. Cost effectiveness of the direct measurement of 3-beta-hydroxybutyrate in the management of diabetic ketoacidosis in children.  Diabetes Care. 2003;  26 959 , (letter)
• 36 Vanelli M, Chiari G, Ghizzoni L, Costi G, Giacalone T, Chiarelli F. Effectiveness of a prevention program for diabetic ketoacidosis in children.  Diabetes Care. 1999;  22 7-9

Correspondence